Overview

Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study tested the hypothesis that response to digoxin is modulated by single Nucleotid Polymorphism (SNP): - Multi Drug Resistance (MDR1) gene haplotypes and Solute carrier organic anion transporter family member 1B3 (SLCO1B3) gene Polymorphism and their role in the response to treatement. - Aldosterone synthase (CYP11B2) gene and sodium channel, voltage-gated, type V alpha subunit gene (SCN5A) correlated with atrial fibrillation and their roles in response to digoxin.
Details
Lead Sponsor:
University of Monastir
Treatments:
Digoxin